-
1
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
2
المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar
المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test -
3
المؤلفون: Steven M. Townson, James Larkin, Emilie Scherrer, Reina Rau, Irene Shui, Maria Lorenzi
المصدر: Future oncology (London, England). 17(20)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Clinical Decision-Making, Programmed Cell Death 1 Receptor, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Overall survival, Biomarkers, Tumor, Humans, Immune Checkpoint Inhibitors, Melanoma, Advanced melanoma, business.industry, Patient Selection, Anti pd 1, General Medicine, medicine.disease, Progression-Free Survival, 030104 developmental biology, Systematic review, 030220 oncology & carcinogenesis, Biomarker (medicine), business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c394dfb2529278b1dd27e417d8c10cTest
https://pubmed.ncbi.nlm.nih.gov/33783230Test -
4
المؤلفون: Emilie Scherrer, Wanmei Ou, Eric D. Whitman, Clemens Krepler
المصدر: Future oncology (London, England). 16(20)
مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, medicine, Humans, In patient, Melanoma, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Anti pd 1, Retrospective cohort study, General Medicine, Immunotherapy, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, Retreatment, Female, Outcomes research, business, Progressive disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecb7e4b6384a254b88279aeefff942cTest
https://pubmed.ncbi.nlm.nih.gov/32410465Test -
5
المؤلفون: Emilie Scherrer, Rachael Miller, Agnes Brandtmüller, Kevin Cadwell, Irene Shui, Sophie Walker
المصدر: Melanoma Management
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, skin (melanoma), MEDLINE, Review, Dermatology, Disease, survival, cutaneous melanoma, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Epidemiology, medicine, Adjuvant therapy, cancer, Stage (cooking), business.industry, Incidence (epidemiology), Cancer, adjuvant therapy, staging, medicine.disease, mortality, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cutaneous melanoma, incidence, epidemiology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5f4697850e66ab1ac2440612678698Test
https://doi.org/10.2217/mmt-2019-0022Test